Global Cord Blood Corporation

Equities

CORBF

KYG393421030

Healthcare Facilities & Services

Market Closed - OTC Markets Other stock markets 03:04:15 2024-04-26 pm EDT			5-day change	1st Jan Change
1.25 ^USD	0.00%		0.00%	+2.46%

2023	Global Cord Blood Corporation Announces Board Appointments	CI
2023	Global Cord Blood Corporation(NYSE:CO) dropped from S&P Global BMI Index	CI

Global Cord Blood Corporation Proposes Board Changes

June 03, 2022 at 09:17 am EDT

Global Cord Blood Corporation at the EGM to be held on June 16, 2022 proposes removal of the following directors from office of the Company with immediate effect: Ting Zheng, Albert Chen, Mark D. Chen, Jack Chow, Dr. Ken Lu, Jennifer J. Weng and Jacky Cheng.

Latest news about Global Cord Blood Corporation

Global Cord Blood Corporation Announces Board Appointments	23-09-29	CI
Global Cord Blood Corporation(NYSE:CO) dropped from S&P Global BMI Index	23-03-20	CI
Global Cord Blood Corporation Announces Board Changes	23-02-17	CI
China Cord Blood Posts Lower Fiscal Q4 Profit, Revenue	22-07-06	MT
Global Cord Blood Corporation Reports Earnings Results for the Full Year Ended March 31, 2022	22-07-05	CI
Earnings Flash (CO) GLOBAL CORD BLOOD CORPORATION Posts Q4 EPS $0.14	22-07-05	MT
Global Cord Blood Corporation Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	22-07-05	CI
Global Cord Blood Shares Rise 15% After Merger Target Gets FDA Clearance for IND	22-06-17	DJ
Global Cord Says Cellenkos Gets US FDA OK of IND Application for CK0804 as Add-on Therapy to Ruxolitinib for Myelofibrosis	22-06-16	MT
Global Cord Blood Corporation Approves Board Changes	22-06-16	CI
Global Cord Blood Shareholder Blue Ocean Says EGM Called to Vote on Cellenkos Deal Cancelation Proposal	22-06-03	MT
Global Cord Blood Corporation Proposes Board Changes	22-06-03	CI
Global Cord Blood Corporation (NYSE:CO) cancelled the acquisition of an unknown stake in Cellenkos, Inc. from Leong Kim Chuan.	22-05-19	CI
Blue Ocean Structure Provides Information to Shareholders of Global Cord	22-05-13	CI
Blue Ocean Structure Investment Company Limited Communicates with Global Cord Blood Corporation	22-05-13	CI
Blue Ocean Structure Investment Company Limited Sues Global Cord Blood Corporation	22-05-09	CI
China Cord Blood's Stock Down 35%; Announces Acquisition of Cellenkos	22-05-02	MT
Global Cord Blood Corporation (NYSE : CO) entered into an agreement to acquire an unknown stake in Cellenkos, Inc. from Leong Kim Chuan.	22-04-28	CI
Transcript : Global Cord Blood Corporation, Q3 2022 Earnings Call, Mar 01, 2022	22-03-01
Global Cord Blood Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-28	CI
Health Care Stocks Point Lower Premarket Friday	21-12-17	MT
Global Cord Blood Rejects Takeover Bid From Alternate Ocean Investment	21-12-16	MT
Unknown buyers cancelled the acquisition of Global Cord Blood Corporation (NYSE:CO) from Blue Ocean Structure Investment Company Ltd. and others.	21-12-15	CI
Transcript : Global Cord Blood Corporation, Q2 2022 Earnings Call, Nov 26, 2021	21-11-26
Global Cord Blood Corporation Posts Lower Q2 Profit Amid Higher Revenue -- Stock Up 2% After-Hours	21-11-24	MT

Chart Global Cord Blood Corporation

Duration

Period

More charts

Company Profile

Global Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.

Sector

Healthcare Facilities & Services

More about the company

Income Statement Evolution

More financial data

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
GLOBAL CORD BLOOD CORPORATION	+2.46%	167M
CVS HEALTH CORPORATION	-14.92%	84.68B
HCA HEALTHCARE, INC.	+13.30%	81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+11.62%	29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-12.71%	16.73B
FRESENIUS SE & CO. KGAA	-3.06%	16.36B
QUEST DIAGNOSTICS INCORPORATED	-2.63%	14.92B
PURE HEALTH HOLDING	-31.75%	11.77B
FRESENIUS MEDICAL CARE AG	-1.42%	11.72B
DAVITA INC.	+27.44%	11.71B

Other Healthcare Facilities & Services